UK markets closed

Quince Therapeutics, Inc. (QNCX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.9851+0.0251 (+2.61%)
At close: 04:00PM EDT
1.0200 +0.03 (+3.54%)
After hours: 07:13PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
37,623
9,447
25,178
60,795
61,307
Selling general and administrative
30,792
17,695
26,012
29,523
17,586
Total operating expenses
68,415
27,142
51,190
90,318
78,893
Operating income or loss
-68,415
-27,142
-51,190
-90,318
-78,893
Interest expense
-
-
-
-
0
Total other income/expenses net
-2,031
-7,918
-1,822
-247
-
Income before tax
-69,809
-31,582
-51,944
-89,945
-76,849
Income tax expense
-197
-197
-284
0
-
Income from continuing operations
-69,525
-31,385
-51,660
-89,945
-76,849
Net income
-69,525
-31,385
-51,660
-89,945
-76,849
Net income available to common shareholders
-69,525
-31,385
-51,660
-89,945
-76,849
Basic EPS
-0.76
-
-1.54
-3.03
-2.63
Diluted EPS
-0.76
-
-1.54
-3.03
-2.63
Basic average shares
35,884
-
33,497
29,719
29,176
Diluted average shares
35,884
-
33,497
29,719
29,176